文献速递烧伤创面修复

重症烧伤患者主要不良肾脏事件的预测

Prediction of major adverse kidney events in critically ill burn patients.
PubMed 文献 · Burns · 2018-10-12

单中心队列研究纳入87例烧伤面积>20%的重症烧伤患者,评估入院时血浆中性粒细胞明胶酶相关脂质运载蛋白(pNGAL)与严重程度评分对主要不良肾脏事件(MAKE)的预测价值。结果显示pNGAL在MAKE组更高,多因素分析中pNGAL与ABSI与MAKE独立相关,pNGAL加入评分可改善预测与风险重分类。

要点

  • 入院pNGAL在发生MAKE的烧伤患者中显著升高。
  • pNGAL与ABSI是多因素分析中MAKE的独立相关因素。
  • pNGAL加入ABSI等评分可改善MAKE及AKI的预测与重分类。

核心结论

  • 入院pNGAL与重症烧伤患者MAKE风险相关,联合严重程度评分时预测效能优于单纯评分。

研究设计与样本

  • 单中心队列研究,纳入2012年1月至2015年1月连续收治的烧伤总面积>20%且入院时检测pNGAL的重症烧伤患者87例。

主要发现

  • 87例患者平均年龄47.7岁(IQR 33.4-65.2),烧伤总面积40%(IQR 30-55)%,ICU死亡率36%。
  • 39例(44.8%)发生MAKE,32例(88.9%)在90天死亡。
  • MAKE组pNGAL为423 pg/mL(IQR 327-518),高于非MAKE组的184 pg/mL(IQR 147-220),p<0.001。
  • 多因素分析中pNGAL与MAKE相关(OR 1.005,95%CI 1.0005-1.009,p=0.03),ABSI与MAKE相关(OR 1.682,95%CI 1.038-2.726,p=0.035)。

关键数值与推荐

  • MAKE定义为死亡和/或需要肾脏替代治疗(RRT)和/或第90天肾脏未恢复。
  • pNGAL加入ABSI、SOFA和SAPS2后,对MAKE和AKI及多数严重AKI形式的预测优于临床评分。
  • 与ABSI相比,加入pNGAL对MAKE、RRT、第7天AKI及住院期间AKI实现统计学显著的患者重分类。
  • 为多检出1例MAKE需筛查44例,严重AKI需筛查13例,AKI需筛查15例。

临床怎么用

  • 对重症烧伤患者可在入院时检测pNGAL,联合ABSI等评分用于MAKE风险分层。
  • pNGAL联合评分有助于识别需要密切监测肾功能及考虑肾脏替代治疗的高危患者。

局限性

  • 单中心研究,样本量87例,结论外推需谨慎。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We aimed at assessing the predictive value of plasmatic Neutrophil Gelatinase Associated Lipocalin (pNGAL) at admission and severity scores to predict major adverse kidney events (MAKE, defined as death and/or need for renal replacement therapy (RRT) and/or non-renal recovery at day 90) in critically ill burn patients. MATERIAL AND METHODS: Single-center cohort study in a burn critical care unit in a tertiary center, including all consecutive severely burn patients (total burned body surface >20%) from January 2012 until January 2015 with a pNGAL dosage at admission. Reclassification of patients was assessed by Integrated Discrimination Improvement (IDI). MEASUREMENTS AND RESULTS: 87 patients were included. Mean age was 47.7 (IQ 25-75: 33.4-65.2) years; total burn body surface area was 40 (IQ 25-75: 30-55) % and ICU mortality 36%. 39 (44.8%) patients presented a MAKE, 32 (88.9%) patients died at day 90. pNGAL was higher in the MAKE group (423 [IQ 25-75: 327-518]pg/mL vs 184 [IQ 25-75: 147-220]pg/mL, p<0.001). In multivariate analysis, pNGAL and abbreviated burn severity index (ABSI) remained associated with MAKE (OR 1.005 [CI 95% 1.0005-1.009], p=0.03 and OR 1.682 [CI95%1.038-2.726], p=0.035 respectively). Adding pNGAL to abbreviated burn severity index, simplified organ failure assessment and the simplified acute physiology score 2 did outperform clinical scores for the prediction of MAKE and AKI and for most severe forms of AKI and allowed a statistically significant reclassification of patients compared to ABSI for MAKE, RRT, AKI at Day 7 and AKI during hospitalization with a number of patients needed to screen to detect one extra episode of MAKE was 44, 13 for severe AKI and 15 for AKI. CONCLUSIONS: pNGAL at admission is associated with the risk of MAKE in this population, and outperform severity scores when associated. Interventional studies are now needed to assess if impact of biomarkers-guided strategies would improve outcome.

来源:Burns,查看原文。版权归原作者所有。

引用

  1. Dépret F, Boutin L, Jarkovský J, et al. Prediction of major adverse kidney events in critically ill burn patients. Burns. 2018. PMID: 30322739. doi:10.1016/j.burns.2018.08.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。